Acme Universal Safezone 9 IPO Details
Acme Universal Safezone 9 IPO Summary
Acme Universal Safezone 9 IPO opens for subscription on 28 Sep 2026 and closes on 30 Sep 2026.The IPO will be listed on BSE with the tentative listing date set for 06 Oct 2026.
Acme Universal Safezone 9 IPO price band has been fixed at ₹65 – ₹71 per share. The face value is ₹10 per share with a lot size of 1600.
Acme Universal Safezone 9 IPO total issue size comprises 50,60,800 shares (aggregating up to ₹35.93 Cr). This includes a fresh issue of 50,60,800 shares (aggregating up to ₹35.93 Cr). Pre-issue shareholding stands at 1,40,32,620, which will increase to 1,90,93,420 post-issue.
Acme Universal Safezone 9 IPO carries a ₹16 (22.54%) GMP, reflecting investor sentiment.
Acme Universal Safezone 9 IPO Lot Size :Individual Minimum is 2 lots (3,200 shares) amounting to ₹2,27,200. Individual Maximum is 2 lots (3,200 shares) amounting to ₹2,27,200. SHNI Minimum is 3 lots (4,800 shares) amounting to ₹3,40,800. SHNI Maximum is 8 lots (12,800 shares) amounting to ₹9,08,800. BHNI Minimum is 9 lots (14,400 shares) amounting to ₹10,22,400.
Acme Universal Safezone 9 IPO Details
Acme Universal Safezone 9 IPO Subscription
Acme Universal Safezone 9 IPO Application Wise Breakup
Acme Universal Safezone 9 IPO Dates
- 28 Sep 2026Opening dateOpen
- 30 Sep 2026Closing dateClose
- 01 Oct 2026Allotment Date Allotment
- 05 Oct 2026Initiation of RefundsRefund
- 05 Oct 2026Credit of SharesCredit
- 06 Oct 2026Listing dateListing
Acme Universal Safezone 9 IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Individual Minimum | 2 | 3200 | ₹2,27,200 |
| Individual Maximum | 2 | 3200 | ₹2,27,200 |
| SHNI Minimum | 3 | 4800 | ₹3,40,800 |
| SHNI Maximum | 8 | 12800 | ₹9,08,800 |
| BHNI Minimum | 9 | 14400 | ₹10,22,400 |
Acme Universal Safezone 9 IPO Reservation
Promoter Holding
Documents
Acme Universal Safezone 9 IPO Valuations
Acme Universal Safezone 9 Financial Information
| Period Ended | 31 Mar 2026 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Assets | 146.72 | 133.70 | 119.07 |
| Total Income | 211.16 | 191.31 | 181.67 |
| Profit After Tax | 5.86 | 0.80 | 7.56 |
| EBITDA | 15.15 | 9.85 | 14.55 |
| NET Worth | 52.77 | 46.91 | 41.96 |
| Reserves and Surplus | 38.74 | 42.23 | 37.50 |
| Total Borrowing | 58.05 | 49.65 | 44.51 |
| Amount in ₹ Crore | |||
About Acme Universal Safezone 9 IPO
Incorporated in November 2016 (originally established as a partnership firm in April 1994), Acme Universal Safezone 9 Limited is a leading manufacturer of industrial safety footwear under the 'ACME' brand. The company operates in the Personal Protective Equipment (PPE) segment, manufacturing and supplying a wide range of safety shoes for industries such as construction, oil & gas, mining, automotive, pharmaceuticals, chemicals, foundries, and power generation. Its product portfolio includes EVA-Rubber, Nitrile Rubber, and PVC safety footwear compliant with Indian and international standards including IS 15298, EN ISO 20345, ASTM F2413, and SEDEX SMETA.
The company operates five manufacturing facilities across Madhya Pradesh and Uttar Pradesh, supported by advanced manufacturing technologies, SAP S/4 HANA ERP, ICad3D product design, CRM, and HRMS platforms. It serves customers through institutional sales, an extensive distributor and dealer network, e-commerce channels, and exports its products to several international markets including the UAE, Saudi Arabia, Bahrain, Nigeria, Israel, the Netherlands, Hong Kong, Cameroon, and Mauritius.
The company focuses on technology-driven manufacturing, product innovation, international quality standards, and expanding its domestic and global footprint.
As of March 31, 2026, Acme Universal Safezone 9 employed 1,073 professionals across operations, sales, marketing, finance, HR, and IT functions.
Strength Of Acme Universal Safezone 9 IPO
- Experienced Management Team.
- Focus on Quality and Compliance.
- Efficient Manufacturing Processes.
- Cost-Competitive Offerings.
- Diversified Customer Base.
- Strong Customer Relationships.
- Continuous Product Development.
- Growth-Oriented Strategy.
Risk Of Acme Universal Safezone 9 IPO
- The company Offices and Plants are located on leased premises and any disruption in these lease arrangements could adversely affect its business, operations, and financial performance.
- Significant portion of the company's revenue has been generated from some states of India, any loss of business from these states may adversely affect its revenues and profitability.
- The company's revenue is highly concentrated among a small number of customers, with the top 10 customers accounting for 47.71% for the Financial Year ended on March 31, 2026, any reduction in business from these key clients, may cause significant revenue disruption.
- The company failures to perform in accordance with the standards prescribed in work order of its client could result in loss of business or payment of liquidated damages.
- Certain statutory approvals required for the company's manufacturing operations are pending and any delay or refusal in obtaining the same may adversely affect its operations
- If the company experience insufficient cash flows from its operations or are unable to borrow to meet the company working capital requirements, it may materially and adversely affect the company's business, results of operations and cash flows.
- The company is exposed to credit risk from its customers and the recoverability of the company trade receivables is subject to uncertainties.
- Delays in depositing statutory dues including GST, Provident Fund or ESIC contributions may expose it to penalties and regulatory action.
- The company is dependent on its Individual Promoters, the Key Managerial Personnel and the Senior Management Personnel and the loss of, or the company's inability to hire, retain, train, and motivate qualified personnel could adversely affect its business, results of operations and financial condition.
- High dependence on key raw materials (PU/PVC Compound, Leather, Steel Toe Caps) subject to commodity price volatility and import dependency may adversely impact the company cost structures and margins.
Objectives Acme Universal Safezone 9 IPO
1. Funding capital expenditure requirements for the installation of solar power plant
2. Funding capital expenditure requirements towards installation of additional machinery
3. Funding incremental working capital requirements of the Company
4. Funding inorganic growth through unidentified acquisitions and other strategic initiatives and General corporate purposes
Company Contact Details
Near Twelve Shops Girwai Naka A. B. Road,
Gwalior, Madhya Pradesh , 474001
Phone: +91- 91099 71732
Email: compliance@acmeuniversal9.com
Website: https://www.acmeuniversal9.com/
Registrar Contact Details
Acme Universal Safezone 9 FAQs
The Acme Universal Safezone 9 IPO is a SME public issue comprising 5060800 equity shares with a face value of ₹10 each, aggregating to a total issue size of ₹35.93 Cr. The issue price has been fixed at ₹71 per equity share, and the minimum application size is 1600 shares.
The IPO opens for subscription on 28 Sep 2026, and closes on 30 Sep 2026.
Maashitla Securities Pvt Ltd has been appointed as the registrar to the issue. The equity shares are proposed to be listed on the BSE
As of now, the current GMP stands at ₹16 (22.54%).
Quick Links
Comments
